Keyphrases
Assisted Reproductive Technology
100%
Frozen Embryo Transfer
56%
Singleton
54%
High Risk
35%
Fresh Embryo Transfer
28%
Denmark
25%
Academic Performance
22%
Type I Diabetes
22%
Type 1 Diabetes Mellitus (T1DM)
22%
Reproductive Safety
22%
Perinatal Outcome
22%
Register Study
19%
Confidence Interval
19%
Registry-based
18%
Norway
18%
Adjusted Odds Ratio
18%
Nordic Countries
17%
School Performance
17%
Sweden
17%
In Vitro Fertilization
17%
Fresh Blastocyst Transfer
17%
Population-based Cohort Study
16%
Spontaneous Conception
16%
Finland
15%
Blastocyst Transfer
15%
Retrospective Cohort Study
15%
Nationwide Registry
15%
Hypertensive Disorders of Pregnancy
14%
Birth Timing
14%
Obstetric Outcomes
11%
Singleton Pregnancy
11%
Gestational Diabetes
11%
Adjusted Hazard Ratio
10%
Modified Natural Cycle
10%
Cardiovascular Disease
10%
Stillbirth
10%
No Significant Difference
10%
Adverse Perinatal Outcomes
10%
Hazard Ratio
9%
Cardiovascular Risk
9%
Perinatal Risk
9%
Natural Cycle
8%
ART children
8%
Adverse Pregnancy Outcomes
8%
Trial Registration
8%
Fresh Transfer
8%
Maternal Risk
8%
Medical Birth Registry
8%
Cleavage-stage Transfer
8%
Maternal Outcomes
8%
Medicine and Dentistry
Assisted Reproductive Technology
77%
Cohort Analysis
74%
Embryo Transfer
54%
Childbirth
30%
Obstetrics
28%
Conception
25%
Disease
24%
Blastocyst
24%
Insulin Dependent Diabetes Mellitus
22%
Adolescent
22%
Hazard Ratio
19%
Assisted Reproduction
19%
In Vitro Fertilisation
17%
Cardiovascular Disease
17%
Randomized Controlled Trial
16%
Child
16%
Retrospective Cohort Study
15%
Odds Ratio
14%
Supplementation
12%
Gestational Diabetes
11%
Intracytoplasmic Sperm Injection
10%
Stillbirth
10%
First Trimester Pregnancy
8%
Apoplexy
8%
Premature Labor
7%
Spastic Diplegia
7%
Ferritin
7%
Pediatrics
7%
Newborn Death
7%
4 Iodo 2,5 Dimethoxyamphetamine
7%
Hormone Substitution
7%
Pregnancy Complication
7%
Perinatal Exposure
7%
Puberty Disorders
7%
Placenta
7%
Maturity Onset Diabetes of the Young
7%
Menstrual Cycle
7%
Pediatric Cancer
7%
Inflammatory Disorder
7%
Wellbeing
7%
Luteal Phase
7%
Progesterone
7%
Congenital Heart Defect
7%
Birth Rate
7%
Maternal Age
6%
Malignant Neoplasm
6%
Logistic Regression Analysis
5%
Placenta Previa
5%
Iron Deficiency
5%